Radionetics Oncology

Radionetics Oncology is a clinical-stage biotechnology company developing precision radiopharmaceutical treatments for cancer. The company designs small-molecule radioligands that target G-protein-coupled receptors (GPCRs) to selectively deliver targeted radiation therapy to solid tumors, including breast and lung cancer, combining GPCR biology expertise with medicinal chemistry. Radionetics entered a strategic agreement with Eli Lilly in 2024. It was surfaced as a portfolio company of DCVC and added to the API Evangelist network; the company publishes no public developer, API, or technical-integration surface at this time.

Radionetics Oncology is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Radiopharmaceuticals, and Oncology.

🌐 Visit website 📡 Source on GitHub
11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsRadiopharmaceuticalsOncologyPrecision MedicineLife SciencesHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/radionetics-oncology: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 3

The organization behind the API

Website
Website
 About
About
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: radionetics-oncology
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/radionetics-oncology.png
name: Radionetics Oncology
description: Radionetics Oncology is a clinical-stage biotechnology company developing precision radiopharmaceutical treatments
  for cancer. The company designs small-molecule radioligands that target G-protein-coupled receptors (GPCRs) to selectively
  deliver targeted radiation therapy to solid tumors, including breast and lung cancer, combining GPCR biology expertise with
  medicinal chemistry. Radionetics entered a strategic agreement with Eli Lilly in 2024. It was surfaced as a portfolio company
  of DCVC and added to the API Evangelist network; the company publishes no public developer, API, or technical-integration
  surface at this time.
url: https://raw.githubusercontent.com/api-evangelist/radionetics-oncology/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Radiopharmaceuticals
- Oncology
- Precision Medicine
- Life Sciences
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://radionetics.com
- type: About
  url: https://radionetics.com
- type: Contact
  url: https://radionetics.com/contact
- type: PrivacyPolicy
  url: https://radionetics.com/privacy-policy
- type: TermsOfService
  url: https://radionetics.com/terms-of-use
- type: LinkedIn
  url: https://www.linkedin.com/company/radionetics-oncology
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1